Aspire Private Capital LLC Invests $914,000 in Align Technology, Inc. $ALGN

Aspire Private Capital LLC acquired a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 7,302 shares of the medical equipment provider’s stock, valued at approximately $914,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Sentry Investment Management LLC grew its stake in shares of Align Technology by 73.1% in the 3rd quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 79 shares in the last quarter. Steigerwald Gordon & Koch Inc. bought a new position in shares of Align Technology during the third quarter valued at approximately $26,000. Rothschild Investment LLC increased its stake in Align Technology by 140.3% in the second quarter. Rothschild Investment LLC now owns 149 shares of the medical equipment provider’s stock worth $28,000 after purchasing an additional 87 shares during the period. Quent Capital LLC purchased a new position in Align Technology in the 3rd quarter worth about $30,000. Finally, TD Private Client Wealth LLC raised its stake in shares of Align Technology by 135.6% during the third quarter. TD Private Client Wealth LLC now owns 238 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 137 shares in the last quarter. 88.43% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ALGN. Robert W. Baird set a $218.00 price objective on Align Technology in a report on Thursday, February 5th. Piper Sandler raised their price objective on Align Technology from $200.00 to $220.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. UBS Group boosted their target price on shares of Align Technology from $175.00 to $185.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Morgan Stanley boosted their price target on Align Technology from $154.00 to $169.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. Finally, Mizuho increased their price objective on shares of Align Technology from $200.00 to $215.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Seven investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $198.08.

Insider Activity at Align Technology

In other news, EVP John Morici sold 7,969 shares of the stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total value of $1,508,611.39. Following the transaction, the executive vice president owned 8,237 shares in the company, valued at approximately $1,559,346.47. This represents a 49.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.66% of the company’s stock.

Align Technology Trading Up 3.9%

NASDAQ:ALGN opened at $176.12 on Wednesday. Align Technology, Inc. has a 12-month low of $122.00 and a 12-month high of $208.30. The firm has a market cap of $12.55 billion, a PE ratio of 31.12, a price-to-earnings-growth ratio of 1.85 and a beta of 1.79. The stock has a fifty day moving average price of $176.32 and a 200 day moving average price of $153.77.

Align Technology (NASDAQ:ALGN) last released its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, topping analysts’ consensus estimates of $2.99 by $0.30. Align Technology had a net margin of 10.17% and a return on equity of 15.16%. The firm had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.03 billion. During the same period in the prior year, the firm earned $2.44 earnings per share. The business’s quarterly revenue was up 5.3% compared to the same quarter last year. Equities analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology Profile

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.